We find that Braemar’s ratio of 14.61x is trading slightly above its industry peers’ ratio of 14.5x, which means if you buy Braemar today, you’d be paying a relatively sensible price for it. And if ...

Secondly, BMS sealed a major deal with Nektar last week on a next generation immunotherapy NKTR-214, a move which Baum believes could materially increase Opdivo's market share.

BMS-986484 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer.

European mid-market private equity house Inflexion agreed to sell its investment in DR&P to BMS in July. The private equity house had invested in DR&P in 2021. DR&P CEO John Page and managing director ...

BMS-813160 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Here are 5 things I never buy on the ships. Demi Moore wins first-ever acting award for 'The Substance': Read her Golden Globes speech World Record Tuna: The Largest Tuna Ever Caught US Makes ...

Shares in BMS rose nearly 12% after AbbVie's announcement ... It came just a few days after AbbVie agreed a $10.1 billion deal to buy antibody-drug conjugate developer ImmunoGen.

the BMS ensures that an EV accesses the full capacity of its energy source. This article may contain affiliate links that Microsoft and/or the publisher may receive a commission from if you buy a ...

The 3-in-1 E20 also boasts 40% faster charging with cutting-edge BMS technology, reaching full charge in just ... the 3-in-1 ...

In 2024, we survived a national election, weather disasters and the NCAA transfer portal. We lived through Tennessee State ...

Neither has hit its ex-dividend date yet, so investors still have some time to jump on the increased payouts. It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry.